CLINICAL_TRIALS
trial_result
· 2017-08-09
Clinical Trial Update: A Study of Imatinib and Docetaxel in Prostate Cancer [Phase 2]
Summary
Phase 2 study evaluating the combination of imatinib and docetaxel for prostate cancer; results have been posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Leonard Appleman | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-08-09